We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMO icon
1626
Domo
DOMO
$166M
$301K ﹤0.01%
5,947
-592
-9% -$26.9K
IMGN
1627
DELISTED
Immunogen Inc
IMGN
$301K ﹤0.01%
63,123
-8,627
-12% -$47.8K
FTI icon
1628
TechnipFMC
FTI
$30.6B
$300K ﹤0.01%
38,742
-17,254
-31% -$121K
PFSI icon
1629
PennyMac Financial
PFSI
$4.38B
$300K ﹤0.01%
5,643
-1,183
-17% -$71.5K
VSAT icon
1630
Viasat
VSAT
$9.79B
$300K ﹤0.01%
6,144
-897
-13% -$41.3K
CCCC icon
1631
C4 Therapeutics
CCCC
$376M
$299K ﹤0.01%
12,296
-2,989
-20% -$72.6K
NEX
1632
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$299K ﹤0.01%
32,434
-5,355
-14% -$38.4K
CENX icon
1633
Century Aluminum
CENX
$4.57B
$298K ﹤0.01%
11,382
-1,426
-11% -$30K
CRNX icon
1634
Crinetics Pharmaceuticals
CRNX
$8.86B
$298K ﹤0.01%
13,559
-3,196
-19% -$64.7K
CSTL icon
1635
Castle Biosciences
CSTL
$749M
$298K ﹤0.01%
6,625
-1,593
-19% -$65.8K
CXW icon
1636
CoreCivic
CXW
$3.1B
$298K ﹤0.01%
26,685
-3,408
-11% -$33.3K
VSXY
1637
Victoria's Secret
VSXY
$6.64B
$298K ﹤0.01%
5,821
-1,090
-16% -$59.3K
INFN
1638
DELISTED
Infinera Corporation Common Stock
INFN
$298K ﹤0.01%
34,309
-5,662
-14% -$48.6K
HAPN
1639
Happen Inc
HAPN
$2.08B
$296K ﹤0.01%
18,802
-2,878
-13% -$53.3K
MRCY icon
1640
Mercury Systems
MRCY
$6.2B
$295K ﹤0.01%
4,587
-806
-15% -$47.9K
SANA icon
1641
Sana Biotechnology
SANA
$885M
$295K ﹤0.01%
35,713
-9,743
-21% -$78.8K
MNDT
1642
DELISTED
Mandiant, Inc. Common Stock
MNDT
$294K ﹤0.01%
13,168
-4,132
-24% -$76.4K
CLDX icon
1643
Celldex Therapeutics
CLDX
$2.77B
$293K ﹤0.01%
8,628
-1,413
-14% -$45.2K
EPAC icon
1644
Enerpac Tool Group
EPAC
$1.77B
$293K ﹤0.01%
13,433
-1,654
-11% -$31.3K
SAM icon
1645
Boston Beer
SAM
$1.88B
$293K ﹤0.01%
755
-127
-14% -$53K
SAFT icon
1646
Safety Insurance
SAFT
$1.52B
$292K ﹤0.01%
3,212
-397
-11% -$33.9K
INVX
1647
Innovex International
INVX
$1.87B
$292K ﹤0.01%
+7,818
New +$224K
ESI icon
1648
Element Solutions
ESI
$9.12B
$291K ﹤0.01%
13,303
-1,315
-9% -$30.3K
KROS icon
1649
Keros Therapeutics
KROS
$199M
$291K ﹤0.01%
5,349
-1,353
-20% -$69.5K
OFG icon
1650
OFG Bancorp
OFG
$2.21B
$291K ﹤0.01%
10,931
-1,354
-11% -$37.6K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.